Dublin, Ireland-A dimethyl sulfoxide (DMSO) "cocktail" significantly improves pain and quality-of-life scores in interstitial cystitis patients, and the regimen may serve as an alternative to other instillation treatments in patients whose principal complaint is pain rather than frequency and urgency, according to researchers from Gartnavel General Hospital, Glasgow, Scotland.
Jessica Feehan, NP-C, discusses the expanding role of APPs in urology, from clinical leadership and procedures to care coordination and treatment initiation.
Sam S. Chang, MD, MBA, discusses treatment selection after BCG failure, including bladder-sparing options, cystectomy considerations, and the need for sequencing data.
Justin B. Ziemba, MD, discusses clinical factors that help identify patients at increased risk for kidney stone recurrence and guide metabolic evaluation.
Adam Sharp, PhD, BM, MRCP, BSc, discusses preliminary safety and efficacy findings from a phase 1/2 study of gedatolisib plus darolutamide in patients with mCRPC.